[Federal Register: February 6, 2002 (Volume 67, Number 25)]
[Notices]
[Page 5603]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06fe02-76]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Process Analytical Technologies Subcommittee of the Advisory
Committee for Pharmaceutical Science; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Process Analytical Technologies Subcommittee of
the Advisory Committee for Pharmaceutical Science.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on February 25, 2002, from
8:30 a.m. to 5:30 p.m., and February 26, 2002, from 8 a.m. to 5 p.m.:
Location: Holiday Inn, The Ballrooms, Two Montgomery Village Ave.,
Gaithersburg, MD.
Contact Person: Nancy Chamberlin, Center for Drug Evaluation and
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for
express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857,
301-827-7001, or e-mail: CHAMBERLINN@cder.fda.gov, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 12539. Please call the Information Line for
up-to-date information on this meeting.
Agenda: On February 25, 2002, the subcommittee will: (1) Identify
and define technology and regulatory uncertainties/hurdles, possible
solutions, and strategies for the successful implementation of process
analytical technologies (PATs) in pharmaceutical development and
manufacturing; (2) discuss general principles for regulatory
application of PATs including principles of method validation,
specifications, use and validation of chemometric tools, and
feasibility of parametric release concept; and (3) discuss the need for
a general FDA guidance to facilitate the implementation of PATs.
On February 26, 2002, the subcommittee will discuss strategies to
explore issues in the following four focus areas: (1) Product and
process development, (2) process and analytical validation, (3)
chemometrics, and (4) process analytical technologies, applications and
benefits.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the subcommittee.
Written submissions maybe made to the contact person by February 15,
2002. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. on February 25, 2002, and between
approximately 1:30 p.m. and 2 p.m. on February 26, 2002. Time allotted
for each presentation may be limited. Those desiring to make formal
oral presentations should notify the contact person before February 15,
2002, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses of
proposed participants, and an indication of the approximate time
requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Nancy Chamberlin at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: January 31, 2002.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 02-2882 Filed 2-5-02; 8:45 am]
BILLING CODE 4160-01-S